These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10308122)

  • 1. Personal responsibility and the Food and Drug Law.
    Janssen WF
    FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122
    [No Abstract]   [Full Text] [Related]  

  • 2. Labeling regulations: 'prescribe as directed'.
    Regier H
    J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
    [No Abstract]   [Full Text] [Related]  

  • 3. [The doctor's responsibility and risk in the prescribing of drugs].
    Aschenbrenner R
    Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431
    [No Abstract]   [Full Text] [Related]  

  • 4. Tempering power with responsibility.
    Feldmann EG
    J Pharm Sci; 1973 Aug; 62(8):I. PubMed ID: 4725203
    [No Abstract]   [Full Text] [Related]  

  • 5. New law broadens FDA safety authority, renews user fees.
    Fox JL
    Nat Biotechnol; 2007 Nov; 25(11):1189-90. PubMed ID: 17989653
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the medical director in the pharmaceutical industry.
    Lyght CE
    Curr Ther Res Clin Exp; 1975 Apr; 17(4):408-17. PubMed ID: 804390
    [No Abstract]   [Full Text] [Related]  

  • 7. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 8. Implications of the Lannett and Pharmadyne decisions.
    Vetrano AJ
    Am J Hosp Pharm; 1980 Apr; 37(4):537-40. PubMed ID: 7377217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifty years of drug amendments revisited: in easy-to-swallow capsule form.
    Kaplan AH
    Food Drug Law J; 1995; 50 Spec():179-96. PubMed ID: 10343042
    [No Abstract]   [Full Text] [Related]  

  • 10. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug problems and the Common Market. Personal views].
    Andersen AH
    Ugeskr Laeger; 1973 Jun; 135(25):1300-1. PubMed ID: 4800706
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of consultants in the parenteral industry.
    Agalloco JP
    J Parenter Sci Technol; 1986; 40(6):277-83. PubMed ID: 3819981
    [No Abstract]   [Full Text] [Related]  

  • 13. The Food and Drug Administration and freedom of information.
    Radzius JR
    Leg Aspects Med Pract; 1978 Jan; 6(1):52-4. PubMed ID: 750805
    [No Abstract]   [Full Text] [Related]  

  • 14. The parenteral drug industry: recent findings.
    Fry EM
    J Parenter Sci Technol; 1982; 36(2):55-8. PubMed ID: 7077464
    [No Abstract]   [Full Text] [Related]  

  • 15. The drug industry and drug effectiveness.
    Curran WJ
    N Engl J Med; 1970 Aug; 283(6):304-5. PubMed ID: 5427059
    [No Abstract]   [Full Text] [Related]  

  • 16. Knowledge is power: legislative control of drug industry trade secrets.
    O'Reilly JT
    Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug industry trying to change FDA's slow but sure policy.
    Demkovich LE
    Natl J (Wash); 1979 Jul; 11(29):1211-5. PubMed ID: 10242491
    [No Abstract]   [Full Text] [Related]  

  • 18. Pessimistic response to FDA leadership change.
    Kling J
    Nat Biotechnol; 2005 Nov; 23(11):1325. PubMed ID: 16273044
    [No Abstract]   [Full Text] [Related]  

  • 19. An impossible job.
    Nat Biotechnol; 2005 Nov; 23(11):1321. PubMed ID: 16273042
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical costs and the drug industry.
    Schwartz H
    Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.